Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal
KRISTOFFER TRIPPLAAR/SIPA VIA AP
The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario